THE PRECISION IMMUNOTHERAPY COMPANY

Alithea’s highly sensitive and reproducible HLA peptidome characterization can support the development of a variety of therapeutic options especially in the immunotherapy space. We reduce the time to IND for T cell engager, TCR T cell therapy, cancer vaccines, TCR mimic antibodies by providing peptide HLA mass spectrometry data for target validation, on-target toxicity profiling and off-target toxicity profiling.
We also have a HLA peptide database with >1 million peptides from >3000 mass spectrometric measurements that is cloud-accessible for target validation. Ever wondered where your targets are expressed? You can check thousands of measurements instantaneously.